Back to Results
First PageMeta Content
Anatomy / Fingolimod / Sphingosine-1-phosphate / MS Australia / Remyelination / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Immunology / Immune system


Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in
Add to Reading List

Document Date: 2015-03-01 21:43:46

Open Document

File Size: 131,32 KB

Share Result on Facebook

Company

Novartis Australia / Gilenya / /

Country

Australia / /

Event

Product Issues / /

IndustryTerm

strict safety protocols / /

MedicalCondition

multiple sclerosis / disease / headache / diarrhea / infection / MS / back pain / influenza / coughing / /

MedicalTreatment

immunotherapies / /

Organization

Medicare / /

/

Position

Governor / treating neurologist / pharmacist / neurologist / /

Product

nerve cells / /

ProvinceOrState

Mississippi / /

Technology

strict safety protocols / /

URL

www.medicareaustralia.gov.au / www.msra.org.au / www.msaustralia.org.au / /

SocialTag